About this trial
Background
Obesity and physical inactivity contribute substantially to cardiovascular disease risk, diabetes, hypertension, and dyslipidemia. African American women experience disproportionately high rates of obesity and have among the lowest levels of physical activity and greatest sedentary time in the United States. Resource-limited neighborhoods may further constrain physical activity through limited access to safe parks, recreation facilities, walking routes, and other health-promoting resources.
This protocol builds on prior community-based work in Washington, D.C., which demonstrated the feasibility of wearable activity monitoring among predominantly African American women in faith-based, lower-resource communities. It uses community-based participatory research principles and mobile health technology to deliver physical-activity coaching tailored either to individual factors or to available neighborhood resources.
Objectives
Primary objective
To determine whether initiating an adaptive physical-activity intervention with remote, mobile-app coaching tailored to neighborhood physical-activity resources "tailored-to-place" coaching-produces a greater increase in steps per day over approximately three months than standard remote coaching.
Secondary objectives
The study will also:
Compare four embedded adaptive intervention strategies over approximately six months.
Assess the feasibility of remotely measuring weight, blood pressure, and blood glucose using connected devices.
Evaluate effects on cardiometabolic measures, including BMI, blood pressure, lipids, glucose, dietary intake, self-reported physical activity, and smoking.
Examine inflammatory, lipid, immunometabolic, psychosocial, behavioral, and social-determinants-of-health pathways related to physical-activity change.
Evaluate changes in cardiac structure and function and body composition using optional cardiovascular and body-composition MRI.
Assess relationships among sleep, ambulatory blood pressure, menopause-related factors, and immunometabolic markers in a postmenopausal sleep sub-study.
Conduct user-centered testing of the mobile application and wearable/mobile health technologies.
Explore COVID-19 exposure and pandemic-related psychosocial stress as potential confounders of immunologic and psychosocial outcomes.
Eligibility: Inclusion Criteria
Participants must:
Be African American women aged 21-75 years.
Have overweight or obesity, defined as BMI \>=25 kg/m\^2
Live in Washington, D.C., Wards 5, 7, or 8, or in neighboring areas of Prince George's County, Maryland.
Have access to a smartphone compatible with the study application.
Be able to provide informed consent independently.
Speak and read English at approximately an eighth-grade level.
Participants enter a two-week run-in period. Those averaging 7,500 steps per day or fewer and who complete the run-in are eligible for randomization into the intervention.
Main study exclusion criteria
Potential participants are excluded for conditions that could make increased physical activity unsafe or interfere with study assessments, including:
Medical conditions or physical limitations that prohibit safe participation in physical activity.
Recent myocardial infarction, documented obstructive coronary artery disease, recent coronary stenting, or significant decompensated structural heart disease.
Pregnancy; pregnancy status is assessed as applicable during study visits.
Other conditions determined by the investigator to make participation unsafe.
Sleep sub-study eligibility
The optional sleep sub-study is limited to postmenopausal women who are enrolled in or have completed the main study. Additional exclusions include night-shift work, conditions that interfere with overnight polysomnography, recent initiation of sleep-modifying medications, inability to tolerate ambulatory blood-pressure monitoring, and certain arm, vascular, skin, bleeding, or neurologic conditions.
MRI participation is optional and requires separate screening for MRI-incompatible implanted devices or metal and, when applicable, eligibility for gadolinium contrast.
Study design
A six-month adaptive randomized trial will enroll overweight or obese African American women. After a two-week run-in, participants averaging \<=7,500 steps/day will receive either standard mobile-app coaching or coaching tailored to neighborhood physical-activity resources. At three months, nonresponders will be reassigned to intensified coaching. Steps will be measured with a wearable device, with assessments at baseline, three months, and six months. Optional monitoring and MRI/sleep sub-studies will assess cardiometabolic outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Medical condition, including heart failure, recent unintentional weight loss or physical limitation, that might prohibit safe participation in physical activity for any reason
Heart disease as indicated by history of myocardial infarction in past 1 year, documented obstructive coronary artery disease on coronary angiography, coronary artery stent placement within the last year significant structural heart disease (e.g. hypertrophic or dilated cardiomyopathy with EF <35%, severe valvular heart disease) with evidence of decompensation.
Pregnant women due to large hormonal changes during pregnancy that affect study variables and potential pregnancy-related restrictions on exercise. All participants of childbearing potential will need to self-report a negative pregnancy at the screening visit, baseline visit, and at the three-month and six-month visits, unless the participant self-reports being postmenopausal, having had a tubal ligation, or having undergone a complete hysterectomy.
Must be an African-American female
Trial design
Sequential
Treatments tested in this trial
AMRA(r) Researcher Image reconstruction software
DeviceImage reconstruction software
MRI: radiofrequency coils (Device Manufacturer: Siemens Medical Solutions USA, Inc.)
Deviceradiofrequency coils
MRI: Research pulse sequences (Device Manufacturer: NIH)
Devicepulse sequences
MRI: Image Reconstruction and Analysis Software (Device Manufacturer: NIH)
DeviceImage Reconstruction and Analysis Software
Bluetooth-enabled glucometer
DeviceBluetooth-enabled glucometer
Remote tailored-to-place coaching (TPC)
DeviceProvides SRC components plus recommendations based on physical-activity resources near the participant s home, work, or church. Messages may recommend parks, recreation centers, exercise classes, trails, greenspaces, or walking routes within an approximately 0.75-mile radius.
Standard remote coaching (SRC)
Other interventionProvides individual-level physical-activity coaching based on goal setting, self-efficacy, barriers, personal preferences, and step data. Educational content is adapted from the Diabetes Prevention Program. Messaging encourages progression toward 10,000 steps/day.
Run-in physical-activity monitoring
DeviceParticipants self-monitor activity during an approximately 2-week run-in period without receiving intervention messaging. Participants averaging 7,500 steps/day proceed to randomization.
Ambulatory blood-pressure monitor
DeviceMeasures systolic and diastolic blood pressure and pulse over approximately 48 hours during usual daily activities.
Polysomnography equipment
DeviceOvernight monitoring using EEG, EOG, EMG, ECG, respiratory airflow and effort, oxygen saturation, body position, snoring, and leg-movement sensors to characterize sleep, including slow-wave sleep.
Treatment groups
Trial outcomes
Primary outcomes
Change in physical activity, measured as average steps per day
Compare the change in objectively measured daily step counts between participants initially assigned to remote coaching tailored to neighborhood physical-activity resources (tailored-to-place coaching) and those assigned to standard remote coaching. Steps are captured by a wrist-worn physical-activity monitor and summarized as average steps per day. The protocol's primary treatment effect is based on the average weekly step counts during the final four weeks of the six-month intervention, approximately weeks 21-24 for the longer-term adaptive intervention analysis.
Secondary outcomes
Cardiac structure, function, and perfusion
Assess changes in biventricular and left-ventricular structure and function, myocardial characteristics, and vasodilator stress perfusion using cardiovascular magnetic resonance in an optional subset.
Mobile-health technology feasibility and acceptability
Evaluate usability, acceptability, functionality, engagement, message delivery, app use, wearable-device adherence, and completion of ecological momentary assessments and educational modules.
Psychosocial and behavioral mediators
Assess chronic psychological and environmental stress, social support and isolation, perceived discrimination, neighborhood environment, sedentary behavior, sleep quality and duration, and other factors that may mediate or modify the relationship between physical activity and cardiovascular health.
Inflammatory and immunometabolic biomarkers
Characterize changes associated with increasing physical activity in cytokines, chemokines, lipid inflammatory intermediates, vascular/endothelial markers, immune-cell measures, and related inflammatory pathways.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
National Heart, Lung, and Blood Institute (NHLBI)
Lead sponsor
George Washington University
Collaborator